Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Coherus Biosciences, Inc. (CHRS)  
$2.27 0.10 (4.61%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,625,000
Market Cap: 187.56(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.59 - $8.14
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of immunotherapies to treat cancer. Co. in-licensed its lead immuno-oncology product candidate, toripalimab (CHS-007), an anti-PD-1 antibody, from Shanghai Junshi Biosciences Co., Ltd. Toripalimab is being evaluated in late-stage clinical trials for the treatment of a range of tumor types. Co.'s commercial portfolio includes two U.S. Food and Drug Administration-approved biologics, including UDENYCA® (pegfilgrastim-cbqv), a biosimilar to Neulasta®, a granulocyte-colony stimulating factor and YUSIMRY™ (adalimumab-aqvh), its Humira® (adalimumab) biosimilar product.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 223,100 223,100 223,100
Total Sell Value $0 $449,770 $449,770 $449,770
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 312
  Page 3 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-02-01 4 AS $21.55 $159,513 D/D (7,402) 61,295 -18%     
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-02-01 4 OE $10.05 $74,390 D/D 7,402 68,697     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-01-25 4 AS $19.00 $920,736 D/D (46,144) 61,295 -32%     
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-01-25 4 OE $10.05 $402,000 D/D 40,000 107,439     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-01-19 4 AS $17.94 $44,852 D/D (2,500) 59,739 -27%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-01-19 4 OE $2.50 $6,251 D/D 2,500 62,239     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-01-11 4 A $0.00 $0 D/D 31,250 59,739     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2021-01-11 4 A $0.00 $0 D/D 31,250 65,146     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-01-11 4 A $0.00 $0 D/D 31,250 67,439     -
   Viret Jean-Frederic Chief Financial Officer   •       –      –    2021-01-10 4 D $18.18 $74,174 D/D (4,080) 36,189     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2021-01-10 4 D $18.18 $74,174 D/D (4,080) 28,489     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2021-01-10 4 D $18.18 $74,174 D/D (4,080) 33,896     -
   Mendelson Alan C Director   –       •      –    2021-01-05 3 IO $0.00 $0 I/I 0 2,569 -10%     
   Mendelson Alan C Director   –       •      –    2021-01-05 3 IO $0.00 $0 D/D 0 1,000 -10%     
   Stolper Mark Director   –       •      –    2021-01-05 3 IO $0.00 $0 I/I 0 8,800 -10%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-17 4 AS $17.51 $43,780 D/D (2,500) 32,569 -17%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-17 4 OE $2.50 $6,251 D/D 2,500 35,069     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-12-10 4 S $18.05 $318,066 D/D (17,626) 36,673 18%     
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-12-10 4 OE $2.08 $36,729 D/D 17,626 54,299     -
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-12-09 4 S $18.24 $903,084 D/D (49,512) 36,673 19%     
   Vexler Vladimir Chief Scientific Officer   •       –      –    2020-12-09 4 OE $2.08 $62,514 D/D 30,000 86,185     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-07 4 S $18.42 $161,896 D/D (8,791) 32,569 23%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-07 4 OE $12.37 $110,656 D/D 8,791 41,360     -
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-04 4 S $18.85 $923,694 D/D (49,000) 32,569 24%     
   Anicetti Vincent R Chief Operating Officer   •       –      –    2020-12-04 4 OE $12.70 $753,079 D/D 49,000 81,569     -
  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us